Biomedinar is an international, peer-reviewed, open access journal on biomedical and health sciences published quarterly online.

The journal aims to publish content of international relevance, contributing to the advancement of medicine, benefiting readers and authors by accelerating the communication and dissemination of research information with the highest quality.
 

INDEXERS/DIRECTORIES/DATABASES:

Zenodo, EZB, Google Scholar, UniversiteitsBibliotheekGent, Latindex, 

AIM AND SCOPE: Stimulate the production of interdisciplinary biomedical knowledge by publishing studies that explore the intersections between biomedical and health sciences.

Topics of interest include, but are not limited to:
Molecular and Cellular Biology: Studies on the structure and function of biomolecules, gene regulation, cellular signaling, and more.
Genetics and Genomics: Research on genetic variation, disease heredity, genome sequencing, gene therapy, and related topics.
Developmental Biology: Investigation of biological processes from conception to aging, including embryology, tissue regeneration, and cellular aging.
Physiology and Pathophysiology: Studies on the normal and altered functioning of biological systems at the cellular, tissue, and organ levels.
Pharmacology and Therapeutics: Advances in drug discovery and development, pharmacokinetics, pharmacodynamics, and innovative therapies.
Immunology and Vaccinology: Research on the immune system, immunotherapies, vaccines, and immunopathology.
Infectious Diseases: Studies on the epidemiology, pathogenesis, diagnosis, and treatment of infectious diseases, including viruses, bacteria, fungi, and parasites.
Oncology: Research on cancer, including oncogenetics, tumor biology, targeted therapies, and cancer immunotherapy.
Neuroscience and Mental Health: Advances in understanding the brain, neurological and psychiatric disorders, and psychopharmacology.
Bioengineering and Regenerative Medicine: Developments in biomaterials, tissue engineering, artificial organs, 3D bioprinting, and regenerative medicine.
Epidemiology and Public Health: Studies on the distribution and determinants of diseases in human populations, disease prevention, health policies, and global health.
Personalized and Precision Medicine: Research on personalized approaches to diagnosis, treatment, and prevention based on individual genetics and molecular profiles.
 

PERIODICITY: Quarterly

THEMATIC COVERAGE: Interdisciplinary studies that articulate themes of biomedical and health sciences.

TARGET AUDIENCE: Scientific community interested in interdisciplinary studies within the health sciences and related fields.

OPEN ACCESS POLICY: This journal provides immediate open access to its content, following the principle that making scientific knowledge freely available to the public supports a greater global exchange of knowledge.

COST POLICY: There are no submission and peer review fees for the journal Biomedinar. After acceptance, the submitting author must pay the Article Processing Charges (APCs) to have the article published. If the article is not accepted for publication, the author will not pay any fees. For details on APC amounts, please refer to the Instructions and Policies section.

COPYRIGHT POLICY: Authors are solely responsible for the content of their texts and retain the rights to their articles. The journal does not restrict the management of copyrights by the authors.

PRIVACY POLICY: The names and addresses provided to this journal will be used exclusively for the services provided by this publication and will not be made available for other purposes or to third parties.

LICENSE: All articles in this journal adhere to the Creative Commons - Attribution 4.0 International (CC BY 4.0) license.

PEER REVIEW PROCESS: Manuscripts submitted to Biomedinar undergo double-blind peer review by two collaborating professionals. In case of disagreement, the manuscript may be referred to a third reviewer. Biomedinar is committed to ensuring the anonymity of the entire review process.
Articles must be original and unpublished. Articles that have been submitted for evaluation to other journals will not be accepted. The review process involves external reviewers. In case of a disagreement among reviewers, the chief editor may refer the manuscript to a third reviewer to gather more information for decision-making.
In the selection process, three outcomes are considered: the text is approved for publication, the text is returned to the author for modifications, or the text is rejected. Modified texts will be referred back to the same reviewers who evaluated the first version. The standard time for text evaluation is 90 days from the date of receipt.

DECLARATION OF ETHICAL AND PUBLICATION MALPRACTICE: Our declaration is based on the Code of Conduct and Best Practice Guidelines for Journal Editors (Committee on Publication Ethics, 2011). Manuscripts submitted to Biomedinar undergo a thorough originality check using plagiarism detection software before being sent for peer review.